n(1)-methylnicotinamide has been researched along with Kidney Diseases in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maïza, A | 1 |
| Waldek, S | 1 |
| Ballardie, FW | 1 |
| Daley-Yates, PT | 1 |
1 other study available for n(1)-methylnicotinamide and Kidney Diseases
| Article | Year |
|---|---|
Estimation of renal tubular secretion in man, in health and disease, using endogenous N-1-methylnicotinamide.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Creatine; Female; Glomerular Filtration Rate; Humans; Ki | 1992 |